CIK 0001213037
- Non-accelerated filer
- Smaller reporting company
Cardiff Oncology, Inc.
Sign in to watch- Ticker
- CRDF
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272004382
- Phone
- +1 858-952-7570
- Business address
- 11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
- Former names
- Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 9,287 shares (option exercise)
- 4 Option exercise Director acquired 8,484 shares (option exercise)
- 4 Option exercise Director acquired 6,498 shares (option exercise)
- 4 Option exercise Director acquired 8,806 shares (option exercise)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 12,928 shares (to pay taxes)
- 4 Option exercise Director acquired 12,667 shares (option exercise)
- 4 Option exercise Director acquired 5,943 shares (option exercise)
- 4 Open-market sale Director sold 8,334 shares at $0.69 ($5,750)
- 4 Derivatives Options or other derivatives
- 4 Grant or award CEO acquired 745,392 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
Page 10 of 15 · 300 filings